Image de couverture de livre

Impact of Regulatory Interventions on Ulipristal Acetate 5 mg (Esmya) Use in Spain: An Interrupted Time‐Series Analysis

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Marta Monreal‐Di Bello, Diana González‐Bermejo, Belén Castillo‐Cano, Alfonso Rodriguez‐Pascual, Dolores Montero‐Corominas
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Pharmacoepidemiology and Drug Safety
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Handling With Vaccine Type Missing Data in a Dynamic Cohort to Assess the Link Between Time‐Varying Vaccination and an Autoimmune Disease
par: Belén Castillo‐Cano, et autres
Publié: (2024)

Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of Fluoroquinolones
par: Yuchen Guo, et autres
Publié: (2024)

Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non‐melanoma Skin Cancer: An Interrupted Time‐Series Analysis Using Swiss Claims Data
par: Tamino Zappalà, et autres
Publié: (2024)

The Effect of COVID ‐19 Pandemic Restrictions on Laboratory Monitoring of Lithium Treated Outpatients in the Netherlands: A Controlled Interrupted Time Series Analysis
par: Merel Tonn, et autres
Publié: (2026)

COVID ‐19 State of Emergency and Biological Therapy Persistence for Ulcerative Colitis: An Interrupted Time Series Study Using a Nationwide Claims Database
par: Mitsuhiro Mori, et autres
Publié: (2026)

Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations
par: Thomas Goedecke, et autres
Publié: (2024)

Impact and Effectiveness of COVID ‐19 mRNA Vaccination Against COVID ‐19 Hospitalisation in Paediatrics: A Cohort Study Using Two Linked Data Sources in Spain
par: Belén Castillo‐Cano, et autres
Publié: (2025)

Impact of Pharmacovigilance Interventions Targeting Fluoroquinolones on Antibiotic Use in the Netherlands and the United Kingdom
par: Tomas Lasys, et autres
Publié: (2025)

A European, Observational, 3‐Year Cohort Comparative Study on the Safety of the Fixed Dose Combination Pravastatin 40 mg/Fenofibrate 160 mg vs. Statin Alone in Real Clinical Practice: The POSE Study
par: Nikolaos Papadopoulos, et autres
Publié: (2024)

High‐Dose Cyproterone Acetate and Intracranial Meningioma: Impact of the Risk Minimisation Measures Implemented in France in 2018–2019
par: Noémie Roland, et autres
Publié: (2025)

Comparative Effectiveness of Levonorgestrel Implant and Depot Medroxyprogesterone Acetate Injectable for Women Living With HIV on Dolutegravir‐Based Antiretroviral Therapy
par: Katie R. Mollan, et autres
Publié: (2026)

PMDA Perspective on RWD/RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage
par: Kazuhiro Kajiyama, et autres
Publié: (2024)

Antidepressant Use Trajectories and Risk of Discontinuation After Adolescents and Young Adult Cancer Diagnosis
par: Oluwadamilola Onasanya, et autres
Publié: (2025)

Opioid Use After Hip Fracture and Subsequent Fracture Outcomes: A Self‐Controlled Case Series Design
par: Meghan A. Cupp, et autres
Publié: (2025)

Risk of Ischaemic Stroke Varies With Antithrombotic Drugs Use in Proton Pump Inhibitor Users: A Self‐Controlled Case Series Study
par: Min Fan, et autres
Publié: (2025)

Use Patterns of Novel Janus Kinase Inhibitors After the First Safety Alerts: A Nationwide Register‐Based Time Series Analysis
par: Jarno Rutanen, et autres
Publié: (2026)

Post‐Market Evidence for Cancer Medicines in Regulatory and Clinical Decision‐Making: A Scoping Review
par: Eliza J. McEwin, et autres
Publié: (2025)

Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for Neuropathy
par: Florence van Hunsel, et autres
Publié: (2025)

Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID‐19 Adenovirus Vector Vaccines on European Healthcare Professionals
par: Ella van Vliet, et autres
Publié: (2024)

Multiple Perspectives on the Need for Real‐World Evidence to Inform Regulatory and Health Technology Assessment Decision‐Making: Scoping Review and Stakeholder Interviews
par: Marieke S. Jansen, et autres
Publié: (2025)

Use of Valproic Acid Among Women of Childbearing Age and Its Concomitant Use With Contraceptives in Colombia
par: Jorge E. Machado‐Alba, et autres
Publié: (2025)

Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events
par: W. N. Kelly, et autres
Publié: (2024)

Real‐World Data and Real‐World Evidence in Regulatory Decision Making: Report Summary From the Council for International Organizations of Medical Sciences (CIOMS) Working Group XIII
par: Sean Hennessy, et autres
Publié: (2025)

Quantitative Measurement of the Direct Public Health Impact of Medicines Withdrawals in Europe: Development of a Modelling Method and Proof‐of‐Concept Study to Estimate the Morbidity and Mortality Prevented by Regulatory Action
par: Samantha Lane, et autres
Publié: (2024)

Incidence of and Determinants for Substance Use Disorders Among Individuals With Long‐Term Prescription Opioid Use: A Population‐Based Cohort Study
par: Håkon Høydal Nestvold, et autres
Publié: (2025)

Current Use of Common Data Models in the Nordic Countries
par: Gerard Ompad, et autres
Publié: (2025)

Potentially Inappropriate Medication Use in Older Adults With Multimorbidity in Taiwan
par: Betty Chia‐Chen Chang, et autres
Publié: (2024)

Time Windows Used When Identifying Current Drug Use and Polypharmacy
par: Sabrina Giometto, et autres
Publié: (2026)

The Risk of Hypothyroidism With the Use of GLP ‐1 Receptor Agonists in Saudi Arabia
par: Almaha Alfakhri, et autres
Publié: (2026)

Use of Azithromycin Attributable to Acute SARS‐CoV‐2 Infection
par: Carlo Gagliotti, et autres
Publié: (2024)

Trends in Medication Use Among Young Adults and the Covid‐19 Pandemic Effect
par: Meital Zur, et autres
Publié: (2025)

Opioid Use and the Risk of Ventricular Arrhythmias: A Systematic Review and Meta‐Analysis
par: Shahrzad Salmasi, et autres
Publié: (2024)

Perinatal Outcomes After the Use of Kampo Medicines Containing Ephedra During Pregnancy
par: Aoi Noda, et autres
Publié: (2025)

Hydrochlorothiazide Use and Risk of Skin Cancer: A Population‐Based Retrospective Cohort Study
par: Avery Shuei‐He Yang, et autres
Publié: (2024)

Increasing Prevalence of Long‐Term Antidepressant Use in Australia: A Retrospective Observational Study
par: R. A. D. L. M. K. Ranwala, et autres
Publié: (2025)

Beta Blocker Use and Total Knee Arthroplasty Among United States Medicare Beneficiaries
par: Shailina Keshwani, et autres
Publié: (2026)

Identifying Extended‐Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data
par: Rachael K. Ross, et autres
Publié: (2025)

Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded Indications
par: Anjali D. Deshmukh, et autres
Publié: (2024)

Mental Health and Medicine Use for Headache: A Nationally Representative Study of Adolescents in Denmark
par: Bjørn Evald Holstein, et autres
Publié: (2024)

Capturing Pediatric Health and Medication Use in a US National Health Data Network
par: Ashley I. Michnick, et autres
Publié: (2025)